Product Code: 136838-05-23
Biopreservation Market is Expected to Grow at 9.5% by 2031. The process of applying natural or controlled antimicrobials to preserve food materials for extending its shelf life is known as biopreservation. The biopreservation process is usually carried out with the help of lactic acid bacteria (LAB) as they are inhibitory to microbes responsible for food spoilage. The key agents applied in biopreservation process are lactic acid bacteria, yeast, and bacteriophages. The process is carried out to preserve materials such as meat, seafood, and other food materials. The biopreservation market can be segmented as products, applications, and cell providers. The product category of biopreservation market is segmented as media, equipment, and lab information management systems. In addition equipment segment can be further sub-segmented as freezers, refrigerators, liquid nitrogen tanks and consumables; whereas, media segment is further sub-segmented as pre-formulated media and home-brew media. The key applications of biopreservation process are in biobanking, regenerative medicine, and drug discovery. The key cell providers are segmented as CD19+, tumor cells, CD34+, iPSC, MSC, and hESC.
The key factors assisting the growth of biopreservation market are government initiatives in the form of funds, grants, contracts and other funding systems have led to the growth in the research and development activities of the companies and various research organizations. Thus, this event is expected to lead the progress of new bio-preservation services which are further expected to boost application rates during the forecast period 2016 - 2022. Periodic increase in the application areas of bio-preservation is one of the key contributors towards the overall growth of the biopreservation market. North America was observed as the largest biopreservation market due to introduction of new drug developments and therapies in biomedical research and rise in the population requiring diagnosis and treatment of acute and chronic diseases in this region.
Key Players Identified for Biopreservation Market Include but are Not Limited to:
Azenta US, Inc., Biomatrica, Inc., BioLife Solutions, MVE Biological Solutions, LabVantage Solutions, Inc., Taylor-Wharton., Thermo Fisher Scientific, Inc., Panasonic Corporation, X-Therma Inc., PrincetonCryo., Stirling Ultracold And Other Notable Players.
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Biopreservation market are as follows:
- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Biopreservation market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Segmentation
Product
- Media
- Home-Brew Media
- Pre-formulated Media
- Equipment
- Freezers
- Refrigerators
- Liquid Nitrogen Tanks
- Consumables
- Lab Information Management Systems
Application
- Regenerative Medicine
- Biobanking
- Drug Discovery
Cell Providers
- CD34+
- CD19+
- MSC
- iPSC
- hESC
- Tumor Cells
Region Segment (2021-2031; US$ Million)
- North America
- U.S.
- Canada
- Rest of North America
- UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa
Key questions answered in this report:
- What are the key micro and macro environmental factors that are impacting the growth of Biopreservation market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Biopreservation market?
- Which is the largest regional market for Biopreservation market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Biopreservation market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Biopreservation market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Biopreservation Market
- 2.2. Global Biopreservation Market, By Product, 2022 (US$ Million)
- 2.3. Global Biopreservation Market, By Application, 2022 (US$ Million)
- 2.4. Global Biopreservation Market, By Cell Providers, 2022 (US$ Million)
- 2.5. Global Biopreservation Market, By Geography, 2022 (US$ Million)
- 2.6. Attractive Investment Proposition by Geography, 2022
3. Biopreservation Market: Competitive Analysis
- 3.1. Market Positioning of Key Biopreservation Market Vendors
- 3.2. Strategies Adopted by Biopreservation Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2022 Versus 2031
4. Biopreservation Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Biopreservation Market Value, 2021 - 2031, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2022 Versus 2031
- 5.3. Market Segmentation
- 5.3.1. Media
- 5.3.1.1. Home-Brew Media
- 5.3.1.2. Pre-formulated Media
- 5.3.2. Equipment
- 5.3.2.1. Freezers
- 5.3.2.2. Refrigerators
- 5.3.2.3. Liquid Nitrogen Tanks
- 5.3.2.4. Consumables
- 5.3.3. Lab Information Management Systems
6. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2022 Versus 2031
- 6.3. Market Segmentation
- 6.3.1. Regenerative Medicine
- 6.3.2. Biobanking
- 6.3.3. Drug Discovery
7. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2022 Versus 2031
- 7.3. Market Segmentation
- 7.3.1. CD34+
- 7.3.2. CD19+
- 7.3.3. MSC
- 7.3.4. iPSC
- 7.3.5. hESC
- 7.3.6. Tumor Cells
8. North America Biopreservation Market, 2021-2031, USD (Million)
- 8.1. Market Overview
- 8.2. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 8.3. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 8.4. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 8.5.Biopreservation Market: By Region, 2021-2031, USD (Million)
- 8.5.1.North America
- 8.5.1.1. U.S.
- 8.5.1.1.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 8.5.1.1.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 8.5.1.1.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 8.5.1.2. Canada
- 8.5.1.2.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 8.5.1.2.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 8.5.1.2.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 8.5.1.3. Rest of North America
- 8.5.1.3.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 8.5.1.3.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 8.5.1.3.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
9. UK and European Union Biopreservation Market, 2021-2031, USD (Million)
- 9.1. Market Overview
- 9.2. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 9.3. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 9.4. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 9.5.Biopreservation Market: By Region, 2021-2031, USD (Million)
- 9.5.1.UK and European Union
- 9.5.1.1. UK
- 9.5.1.1.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 9.5.1.1.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 9.5.1.1.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 9.5.1.2. Germany
- 9.5.1.2.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 9.5.1.2.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 9.5.1.2.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 9.5.1.3. Spain
- 9.5.1.3.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 9.5.1.3.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 9.5.1.3.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 9.5.1.4. Italy
- 9.5.1.4.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 9.5.1.4.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 9.5.1.4.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 9.5.1.5. France
- 9.5.1.5.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 9.5.1.5.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 9.5.1.5.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 9.5.1.6. Rest of Europe
- 9.5.1.6.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 9.5.1.6.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 9.5.1.6.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
10. Asia Pacific Biopreservation Market, 2021-2031, USD (Million)
- 10.1. Market Overview
- 10.2. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 10.3. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 10.4. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 10.5.Biopreservation Market: By Region, 2021-2031, USD (Million)
- 10.5.1.Asia Pacific
- 10.5.1.1. China
- 10.5.1.1.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 10.5.1.1.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 10.5.1.1.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 10.5.1.2. Japan
- 10.5.1.2.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 10.5.1.2.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 10.5.1.2.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 10.5.1.3. India
- 10.5.1.3.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 10.5.1.3.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 10.5.1.3.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 10.5.1.4. Australia
- 10.5.1.4.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 10.5.1.4.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 10.5.1.4.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 10.5.1.5. South Korea
- 10.5.1.5.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 10.5.1.5.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 10.5.1.5.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 10.5.1.6. Rest of Asia Pacific
- 10.5.1.6.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 10.5.1.6.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 10.5.1.6.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
11. Latin America Biopreservation Market, 2021-2031, USD (Million)
- 11.1. Market Overview
- 11.2. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 11.3. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 11.4. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 11.5.Biopreservation Market: By Region, 2021-2031, USD (Million)
- 11.5.1.Latin America
- 11.5.1.1. Brazil
- 11.5.1.1.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 11.5.1.1.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 11.5.1.1.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 11.5.1.2. Mexico
- 11.5.1.2.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 11.5.1.2.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 11.5.1.2.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 11.5.1.3. Rest of Latin America
- 11.5.1.3.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 11.5.1.3.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 11.5.1.3.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
12. Middle East and Africa Biopreservation Market, 2021-2031, USD (Million)
- 12.1. Market Overview
- 12.2. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 12.3. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 12.4. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 12.5.Biopreservation Market: By Region, 2021-2031, USD (Million)
- 12.5.1.Middle East and Africa
- 12.5.1.1. GCC
- 12.5.1.1.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 12.5.1.1.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 12.5.1.1.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 12.5.1.2. Africa
- 12.5.1.2.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 12.5.1.2.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 12.5.1.2.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
- 12.5.1.3. Rest of Middle East and Africa
- 12.5.1.3.1. Biopreservation Market: By Product, 2021-2031, USD (Million)
- 12.5.1.3.1. Biopreservation Market: By Application, 2021-2031, USD (Million)
- 12.5.1.3.1. Biopreservation Market: By Cell Providers, 2021-2031, USD (Million)
13. Company Profile
- 13.1. Azenta US, Inc.
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
- 13.2. Biomatrica, Inc.
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
- 13.3. BioLife Solutions
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
- 13.4. MVE Biological Solutions
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
- 13.5. LabVantage Solutions, Inc.
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
- 13.6. Taylor-Wharton.
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
- 13.7. Thermo Fisher Scientific, Inc.
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
- 13.8. Panasonic Corporation
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
- 13.9. X-Therma Inc.
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
- 13.10. PrincetonCryo.
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
- 13.11. Stirling Ultracold
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
- 13.12. Other Notable Players
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Portfolio
- 13.12.4. Strategic Initiatives